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INTRODUCTION
Recent investigations of the specific sites of action for alcohols and anesthetics have focused on the role of target proteins in the central nervous system, including the γ-aminobutyric acid type A (GABA A ) receptor. Functional GABA A receptors are composed of five homologous subunits positioned around a central chloride channel (Hevers and Luddens, 1998) , with the GABA binding site situated at the α-β interface (Newell and Czajkowski, 2003) . In brain, the predominant subunit stoichiometry of GABA A receptors is 2α, 2β, and 1γ (Tretter et al., 1997; Sieghart and Sperk, 2002) , however there is a subpopulation of extrasynaptic receptors in which certain α and β subunits co-assemble with the δ subunit (Olsen & Sieghart, 2008) . The structure of each subunit consists of an extracellular N-terminal domain, a transmembrane domain with four alpha helical segments (TM1, TM2, TM3, and TM4), an intracellular loop between TM3 and TM4, and an extracellular C-terminal domain (Ortells and Lunt, 1995) . TM2 amino acid residues from each subunit presumably contribute to the ion pore of the chloride channel (Xu and Akabas, 1996; Miyazawa et al., 2003) .
Alcohols and volatile anesthetics positively modulate GABA A receptor function (Lovinger, 1997; Harris, 1999; Franks, 2008) , and recent studies have identified alcohol-binding sites in this receptor (Mihic et al., 1997; Mascia et al., 2000; Jung et al., 2005; Perkins et al., 2009) . Specifically, studies using point mutations and heterologous expression systems provide evidence that homologous TM2 positions in the GABA A receptor α 1 , α 2 , and β 1 subunits and the glycine receptor α 1 subunit are important for the actions of alcohols and This article has not been copyedited and formatted. The final version may differ from this version.
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anesthetics. For example, Mihic et al. (1997) found that mutant α 1 (S270I) β 1 , α 2 (S270I) β 1 , and α 1 β 1 (S265I) GABA A receptors and α 1 (S267I) glycine receptors were resistant to enhancement by ethanol or enflurane. Similarly, Ueno et al. (1999) reported that the potentiating effects of ethanol were abolished in mutant α 2 (S270I)β 1 γ 2L and α 2 β 1 (S265I) γ 2L receptors, and Jenkins et al. (2001) found that S270 of the GABA A receptor α subunits contributes to a common site of action for the inhalation anesthetics chloroform, halothane, and isoflurane. It has been further proposed that these residues, along with residues from the other TM domains, contribute to a water-filled, intrasubunit binding pocket (Yamakura et al., 2001; Trudell & Bertaccini, 2004; McCracken et al., 2010) . In addition, residues in the γ and δ subunits may also contribute to alcohol binding sites (Perkins et al. 2009; Olsen and Sieghart, 2009) , however currently, the role of these subunits is not well defined.
Although recent studies have alternatively proposed the presence of a general anesthetic binding pocket at the GABA A receptor α-β interface (Li et al., 2010) , it has been shown that the 265 position of the GABA A receptor β subunit is necessary for the actions of the injectable anesthetic etomidate (Belelli et al., 1997) , and two knock-in mice, β 2 (N265S) and β 3 (N265M), have been constructed to investigate the behavioral effects of injectable anesthetics in vivo (Jurd et al., 2003; Reynolds et al., 2003; Sanchis-Segura et al., 2007) . In contrast to these studies of injectable anesthetics, the role of the GABA A receptor β 2 subunit in alcohol and inhaled anesthetic action has not been as extensively studied.
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Therefore, the aim of the present study was to investigate whether N265 in the GABA A receptor β 2 subunit, which is homologous to the implicated sites in TM2 of the α 1 , α 2 , and β 1 subunits, is important for alcohol and anesthetic action. Figure 1 shows the relative positions of β 2 (I264, 14') and β 2 (N265, 15') residues in TM2 of α 1 β 2 γ 2S GABA A receptors, based on the X-ray structure of the prokaryotic proton-gated ion channel GLIC (Bocquet et al., 2009 ). Specifically, we asked whether the individual mutation of this amino acid residue to cysteine affected receptor sensitivity to alcohols and if octyl methanethiosulfonate (OMTS), an alcohol/anesthetic analog, covalently reacted with the substituted cysteine and irreversibly altered GABA-induced currents. Propyl methanethiosulfonate (PMTS) covalently reacts with the substituted cysteine in mutant α 2 (S270C)β 1 receptors and irreversibly potentiates GABA-induced currents, mimicking the effects of alcohol and anesthetics (Mascia et al., 2000) .
We hypothesized that if the substituted cysteine in the homologous position of the β 2 subunit contributes to an alcohol and anesthetic binding site, then it would covalently react with OMTS, resulting in the irreversible attachment of octyl thiol to the cysteine thiol group. With the octyl thiol covalently bound at position 265, it was expected that GABA-induced current would be irreversibly potentiated and subsequently applied alcohols or anesthetics would be unable to bind and modulate receptor function.
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Mutagenesis and Transcription
Mutations were achieved using a QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA). Complementary primers containing the desired mutations were designed and polymerase chain reactions (PCR) were performed. Subsequently, Dpn I was used to digest the parental DNA and TOP10/P3 competent cells were transformed with the PCR products. The plasmids of interest were obtained through minipreps and were sent for sequencing to verify the presence of the desired mutations. cRNAs were synthesized using the wild-type and mutant cDNA as a template. Specifically, pCDM8 plasmid encoding human GABA A receptor β 2 subunit and pGEMHE plasmids encoding rat α 1 or γ 2S GABA A receptor subunits were employed to synthesize the cRNAs using T7 RNA polymerase (mMESSAGE mMACHINE T7 Kit, Ambion, Austin, TX).
Electrophysiological Recording
Two-electrode voltage clamp electrophysiology was used to measure GABA-induced currents from oocytes 3-4 days following injection with cRNAs.
Each oocyte was placed in a rectangular chamber (~ 100 μl) and continuously perfused at a rate of 2 ml/min with ND96 buffer (96 mM NaCl, 1 mM CaCl 2 , 2 mM KCl, 1 mM MgCl 2 , 5 mM HEPES, pH 7.5) at room temperature (23ºC). Two glass electrodes containing 3 M KCl were used to achieve a -70 mV holding potential using a Warner Instrument oocyte clamp (Hamden, CT). All solutions were prepared immediately before use and applied by bath perfusion. Effect of Alcohols and Anesthetics on GABA-induced Current. The GABA EC 5 GABA (the concentration that produced 5% of the maximal response) was determined for each oocyte after application of the maximal GABA concentration and served as the test GABA concentration. All test GABA applications were 30 s and were followed by a 5 min washout. The test GABA concentration was applied twice, and the modulator was then preapplied for 1 min, coapplied with GABA for 30 s, and followed by a 5 min washout. The test GABA concentration was applied again, and the percent potentiation of the GABA-induced current by the modulator was calculated for each oocyte. This procedure was used to test 200 mM ethanol, 11 mM, 22 mM and 32 mM butanol as well as 57 µM, 114 µM, and 171 µM octanol. The potentiation of EC 5 GABA-induced current by 1 μM etomidate and 2 mM chloroform was also measured using this protocol.
Effect of OMTS on GABA-induced Current. Two consecutive applications of the test GABA concentration were administered, with the second application representing the initial response. 50 μM OMTS was applied alone for 1 min and was followed by a 5 min washout. Subsequently, three applications of the test GABA concentration were applied and currents were measured as percentages of the initial response. To test the effect of OMTS when the receptor was in the open/desensitized state, the same protocol was followed, with the difference that 50 μM OMTS was coapplied with maximal GABA, and the washout time immediate afterward was extended to 15 min. Additionally, we tested the ability of 114 μM octanol or 0.4 μM flunitrazepam to block the effects of OMTS on the N265C mutant using the protocol described above with the exception that octanol or flunitrazepam was pre-applied for 1 min alone and then coapplied with 50 μM
OMTS.
Effect of Allosteric Modulators Pre-and Post-OMTS Application.
Oocytes received two applications of the test GABA concentration, followed by a 30 s coapplication of the test GABA concentration and the modulator. Following a 5 min washout, the test GABA concentration was applied alone and the potentiation of GABA-induced current by the modulator was calculated. After a 1 min application of 50 μM OMTS and a 5 min washout, the maximal GABA concentration was reapplied and the test concentration was recalculated. The potentiation by the modulator was then measured again as described above.
This protocol was used to test 114 μM octanol, 0.6 mM isoflurane, 0.4 μM flunitrazepam, 3 μM alphaxalone, and 50 μM pentobarbital. However, 11 mM butanol and 0.6 mM isoflurane were applied alone for 1 min prior to being coapplied with the test GABA concentration.
Direct Activation by Etomidate and Pentobarbital. The maximal GABA concentration was applied for 20 s and was followed by a 15 min washout.
Etomidate (10 μM) was then applied for 1 min, and the resulting current was measured as a percentage of the maximal response. The same procedure was used to measure the direct activation after the application of 50 μM OMTS.
Similarly, direct activation by 300 μM pentobarbital was also measured.
Modeling
The relative positions of β 2 (I264, 14') and β 2 (N265, 15') residues in α 1 β 2 γ 2S GABA A receptors were modeled using the best available template for the ion pore of the Cys-loop superfamily of receptors; the prokaryotic proton-gated ion channel GLIC (PDB ID 3EAM) (Bocquet et al., 2009) . In that the structure of GLIC now provides the best information about the likely orientation and position of residues in TM2 (Nury and Corringer, 2010), the model of GABA A β 2 residues was made by simply substituting the two corresponding residues in GLIC with I264 and N265. The positions of the side chains were then optimized automatically with the side chain refinement module of Discovery Studio 2.5.5 using the CHARMm force field (Accelrys Inc, San Diego, CA). 
RESULTS
The goal of our study was to determine whether N265 (15') contributes to an alcohol and anesthetic binding site in the GABA A receptor β 2 subunit. We substituted cysteine for the candidate amino acid and exposed the cysteine mutant to sulfhydryl-specific reagents. Additionally, we constructed a second mutant in which cysteine was substituted at the neighboring residue, I264. Two tryptophan mutants, I264W and T266W, were previously constructed by Nishikawa et al. (2002) , and the effects of volatile anesthetics were tested.
Although submaximal GABA currents were significantly potentiated by both halothane and isoflurane in the mutant tryptophan receptors, the effects were small in the I264W compared to the wild-type. Therefore, we included the I264C mutant (14') in our study to rule out the possibility that I264 also participates in alcohol and volatile anesthetic binding.
The relative positions of β 2 (I264, 14') and β 2 (N265, 15') residues in α 1 β 2 γ 2S GABA A receptors based are shown in a model based on the prokaryotic protongated ion channel GLIC (Bocquet et al., 2009) (Figure 1 ). Although less is known about the structure of GABAaR subunits, compared to nAChR, there is a consensus that residues in TM2 at positions 13' and 17' face into the ion pore.
Since the C-alpha atoms of an alpha helix rotate approximately 100 degrees clockwise with respect to the long axis of the helix; it is reasonable that I264 (14') should face towards TM1 of the same subunit and N265 (15') should face into the center of the subunit, but slightly toward TM3. We should note that Figure 1 depicts the alpha helices as a ribbon that traces the helical backbone carbons. This representation provides a clear depiction of I264 and N265, but is somewhat incomplete because, when all the side chains are rendered as space-filling surfaces, the entire TM domain is essentially filled with atoms, except for spaces in the center of each four-helical bundle and spaces at the interfaces between subunits.
The GABA concentration-response curves show that the β 2 (I264C) and β 2 (N265C) mutations both produced an increase in apparent affinity for GABA (Figure 2 ). This increase was larger for the I264C mutation than N265C; the GABA EC 50 values were 1.5 μM for α 1 β 2 (I264C)γ 2S and 17 μM for α 1 β 2 (N265C)γ 2S vs. 36 μM for the wild-type. In each of the cysteine mutants tested, there was also a slight decrease in the maximal current elicited by saturating concentrations of GABA (5337 nA for α 1 β 2 (I264C)γ 2S and 6114 nA for α 1 β 2 (N265C)γ 2S vs. 7361 for the wild-type).
We next examined whether the β 2 (I264C) or β 2 (N265C) point mutations had an effect on alcohol modulation of GABA-induced currents. The β 2 (N265C) mutation eliminated the enhancement of GABA-induced current by 200 mM ethanol and instead, inhibition was produced (-14 ± 3% vs. 51 ± 5% in wild-type) (data not shown). Additionally, the potentiation of GABA-induced current by butanol was significantly reduced in mutant α 1 β 2 (N265C)γ 2S receptors compared to the wild-type at all concentrations tested ( Figure 3A and B) . Similarly, potentiation by octanol was markedly reduced in mutant α 1 β 2 (N265C)γ 2S receptors ( Figure 3C ). In contrast to the β 2 (N265C) mutation, the β 2 (I264C)
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Next, we tested the β 2 (I264C) and β 2 (N265C) mutants in order to determine whether the substituted cysteines reacted with an MTS reagent consequently altered receptor function. We found that following a 1 min application of 50 μM OMTS, the GABA-induced currents of mutant α 1 β 2 (N265C)γ 2S receptors were irreversibly enhanced ( Figure 4A and B), suggesting that OMTS reacted with the substituted cysteine and resulted in the covalent attachment of octanethiol to the cysteine thiol group. The GABA responses of the β 2 (I264C) mutant, like the wild-type, were not altered following OMTS application ( Figure 4B ). Moreover, there was no effect of OMTS on the β 2 (N265C) mutant when it was applied in the presence of 114 μM octanol ( Figure   4C ), suggesting a competitive interaction between octanol and OMTS at the 265 site. However, 0.4 μM flunitrazepam, which presumably acts at a distinct site from 265, did not block the reaction of OMTS with the substituted cysteine ( Figure 4D ).
In order to address the possibility that I264 is accessible only when the receptor is in the activated or desensitized state, we measured EC 5 GABA responses before and after applying 50 μM OMTS in the presence of maximal GABA. These results were similar to our findings when OMTS was applied while the receptor was in the resting state, and again we observed an irreversible enhancement of the GABA responses of the β 2 (N265C) mutant, but no change in the GABA responses of the β 2 (I264C) mutant or the wild-type (data not shown). PMTS, a smaller sulfhydryl-specific reagent, was also tested on the I264C and N265C mutants in the resting and activated/desensitized states. The potentiating effects on the N265C mutant were similar to those observed with OMTS, though not as robust, and there was no effect on the I264C mutant or the wild-type (data not shown). Because the β 2 (I264C) mutation did not affect receptor modulation by alcohols, and MTS reagents had no apparent effect on the function of these mutant receptors, we focused on the α 1 β 2 (N265C)γ 2S mutant in the remainder of our experiments.
Subsequently, we examined whether the N265C mutation or the application of OMTS altered allosteric modulation. Notably, all of the compounds tested (11 mM butanol, 0.4 μM flunitrazepam, 0.6 mM isoflurane, 50 μM pentobarbital, and 3 µM alphaxalone) produced less potentiation of GABAinduced current in α 1 β 2 (N265C)γ 2S receptors compared to the wild-type prior to the application of OMTS. Nevertheless, the potentiation was still measurable in all cases. In wild-type receptors, OMTS did not alter the potentiation of GABA responses by any of the modulators tested ( Figure 5A ). In mutant α 1 β 2 (N265C)γ 2S receptors, the application of OMTS abolished the effects of octanol and isoflurane, and the potentiation by flunitrazepam and alphaxalone was reduced ( Figure 5B ). However, OMTS did not significantly affect mutant receptor modulation by pentobarbital ( Figure 5B ).
The effects of the cysteine mutation on direct channel activation by 10 μM etomidate and 300 μM pentobarbital were also measured (Table 1) previous finding that volatile anesthetic potentiation is reduced in mutant α 1 β 2 (I264W)γ 2S receptors expressed in HEK 293 cells (Nishikawa et al. 2002) , the I264C mutation in our study did not significantly affect alcohol or volatile anesthetic modulation of mutant α 1 β 2 (I264C)γ 2S receptors. Because alcohol or anesthetic potentiation of GABA-induced current was not affected by the I264C mutation, and there were not apparent functional effects of OMTS on mutant α 1 β 2 (I264C)γ 2S receptors, we propose that I264 is not critical for alcohol and anesthetic action on the GABA A receptor. As depicted in Figure 1 , it is possible that I264 is buried between adjacent TM2 alpha helices and TM1 of its own subunit. As a result, it may not be available for interaction with alcohols or reaction with MTS reagents. Therefore, we focused exclusively on N265 in the remainder of our experiments.
Additional evidence that N265 is a critical site of action for alcohols and volatile anesthetics is provided by our experiments examining the effects of OMTS on allosteric modulation. Notably, we found that butanol, octanol, and isoflurane potentiation were reduced by the cysteine mutation alone and were nearly abolished following the application of OMTS. We propose that an alcohol and volatile anesthetic binding site at position 265 of the β 2 subunit was irreversibly occupied by the covalent attachment of octanethiol to N265C, and consequently prevented butanol, octanol, or isoflurane from binding and further enhancing receptor function. Our finding is in accordance with previous studies on other GABA A receptor subunits, glycine receptors, and nicotinic acetylcholine receptors suggesting that the addition of an alkylthiol group to a substituted appears to contribute to an alcohol/anesthetic binding site, we spectulate that water-filled cavities need to be present in both the α and β subunits in order for alcohols or volatile anesthetics to bind and produce their effects.
In summary, we conclude that N265 of the GABA A receptor β 2 subunit contributes to an intrasubunit alcohol and volatile anesthetic binding site.
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TABLES
Post-OMTS α 1 β 2 (N265C)γ 2S α 1 β 2 (N265C)γ 2S
Post-OMTS 10 μM etomidate 10 ± 2 9 ± 1 0.1 ± 0.1 * 0.2 ± 0.1 300 μM pentobarbital 18 ± 1 16 ± 2 19 ± 4 17 ± 3 * Significant effect of the β 2 (N265C) mutation, p < 0.001 comparing α 1 β 2 (N265C)γ 2S to the wild-type before OMTS application.
